Article Public (all visitors)

Regeneron Antibody Therapy For Covid-19 Enters Late-Stage Trials

Forbes 2020

The trial will assess if the drug may be able to prevent infection among patients who have been exposed and treat those who have been infected with the disease.

View Original Source

Curated by

FoundryBase

Updated 19 days ago

ACADEMIC RESEARCH   HEALTHCARE   MEDICINE  

Save

Bookmark this resource

Browse more

View all Articles

Continue from source

More from source

Browse more from Forbes

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.

Log in to suggest Create account